The key is to respect the biological process, control your variables, and let the science unfold on its own, carefully measured timeline
Based on the monthly dosing efficacy and tolerability demonstrated in this trial, we remain confident in our plan to include a higher 9.6-milligram monthly maintenance dose of PF3944 in Phase 3. The drug was made by developer Metsera, which Pfizer acquired in a bidding war with competitor Novo Nordisk last year
In some cases, clinician-recommended antiemetic strategies may also be helpful
The glucagon receptor component promotes lipid mobilization specifically from adipose tissue, which contributes to improved metabolic markers beyond what the scale shows
What is a prior authorization for a weight loss drug
Meals may feel more satisfying